ResearchAsundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial
ResearchBleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation
ResearchAn update on the taxonomy and functional properties of the probiotic Enterococcus faecium SF68
ResearchCorrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation
ResearchParticipant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation: The PEARL-AF Study
ResearchDietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability
ResearchA Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
ResearchEnterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics
ResearchUse of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
ResearchBudget Impact of Appropriate Low-Dose Aspirin Use for Primary and Secondary Cardiovascular Event Prevention in the Managed Care Setting
ResearchAn efficient thermostable organophosphate hydrolase and its application in pesticide decontamination
ResearchAntiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone
ResearchThe translation initiation factor eIF4A from Schizosaccharomyces pombe is closely related to its mammalian counterpart